LENZ Therapeutics Ownership 2024 | Who Owns LENZ Therapeutics Now?
Institutional Ownership
54.26%
Insider Ownership
9.18%
Retail Ownership
36.56%
Institutional Holders
64.00
LENZ Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -13,929 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -18,164 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -62,753 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -9,133 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -279,194 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -434,467 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,425,980 | -100.00% | - | Mar 31, 2024 |
| BARCLAYS PLC | - | - | - | -82,451 | -100.00% | - | Mar 31, 2024 |
| FMR LLC | - | - | - | -1,050 | -100.00% | - | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -115,490 | -100.00% | - | Mar 31, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -2,677 | -100.00% | - | Mar 31, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -36,530 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -4,058 | -100.00% | - | Mar 31, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -21,871 | -100.00% | - | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -186,048 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -81,785 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -28,538 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -204,778 | -100.00% | - | Mar 31, 2024 |
| INVESCO LTD. | - | - | - | -13,419 | -100.00% | - | Mar 31, 2024 |
| AMALGAMATED BANK | - | - | - | -2,445 | -100.00% | - | Mar 31, 2024 |
LENZ Therapeutics's largest institutional shareholder is AMERICAN INTERNATIONAL GROUP, INC., holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -13,929 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -18,164 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -62,753 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -9,133 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -279,194 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -434,467 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,425,980 | -100.00% | - | Mar 31, 2024 |
| BARCLAYS PLC | - | - | - | -82,451 | -100.00% | - | Mar 31, 2024 |
| FMR LLC | - | - | - | -1,050 | -100.00% | - | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -115,490 | -100.00% | - | Mar 31, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -2,677 | -100.00% | - | Mar 31, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -36,530 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -4,058 | -100.00% | - | Mar 31, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -21,871 | -100.00% | - | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -186,048 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -81,785 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -28,538 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -204,778 | -100.00% | - | Mar 31, 2024 |
| INVESCO LTD. | - | - | - | -13,419 | -100.00% | - | Mar 31, 2024 |
| AMALGAMATED BANK | - | - | - | -2,445 | -100.00% | - | Mar 31, 2024 |
The largest LENZ Therapeutics shareholder by % of total assets is AMERICAN INTERNATIONAL GROUP, INC.. The company owns 0.00 shares of LENZ Therapeutics (GRPH), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORDWAND ADVISORS, LLC | - | - | - | -1,000 | -100.00% | - | Mar 31, 2024 |
| FMR LLC | - | - | - | -1,050 | -100.00% | - | Mar 31, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,340 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -1,700 | -100.00% | - | Mar 31, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -2,314 | -100.00% | - | Mar 31, 2024 |
| AMALGAMATED BANK | - | - | - | -2,445 | -100.00% | - | Mar 31, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -2,677 | -100.00% | - | Mar 31, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -2,873 | -100.00% | - | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -4,000 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -4,058 | -100.00% | - | Mar 31, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -4,510 | -100.00% | - | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -4,521 | -100.00% | - | Mar 31, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -4,613 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -7,673 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -9,133 | -100.00% | - | Mar 31, 2024 |
| MAVEN SECURITIES LTD | - | - | - | -10,000 | -100.00% | - | Mar 31, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -12,368 | -100.00% | - | Mar 31, 2024 |
| INVESCO LTD. | - | - | - | -13,419 | -100.00% | - | Mar 31, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -13,929 | -100.00% | - | Mar 31, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -15,329 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, LENZ Therapeutics's largest institutional buyer is NORDWAND ADVISORS, LLC. The company purchased -1.00K stocks of GRPH, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | - | - | - | -8,538,446 | -100.00% | - | Mar 31, 2024 |
| SAMSARA BIOCAPITAL, LLC | - | - | - | -8,459,314 | -100.00% | - | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -2,491,780 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | - | - | - | -1,760,019 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,425,980 | -100.00% | - | Mar 31, 2024 |
| PROSIGHT MANAGEMENT, LP | - | - | - | -1,351,939 | -100.00% | - | Mar 31, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -820,971 | -100.00% | - | Mar 31, 2024 |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | - | - | - | -703,071 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -581,156 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -555,153 | -100.00% | - | Mar 31, 2024 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -447,416 | -100.00% | - | Mar 31, 2024 |
| SECTORAL ASSET MANAGEMENT INC | - | - | - | -441,829 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -434,467 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -279,194 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -204,778 | -100.00% | - | Mar 31, 2024 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -194,578 | -100.00% | - | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -186,048 | -100.00% | - | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -172,750 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | - | - | - | -135,300 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -131,068 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, LENZ Therapeutics's biggest institutional seller is ECOR1 CAPITAL, LLC. The company sold -8.54M shares of GRPH, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | - | - | - | -8,538,446 | -100.00% | - | Mar 31, 2024 |
| SAMSARA BIOCAPITAL, LLC | - | - | - | -8,459,314 | -100.00% | - | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -2,491,780 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | - | - | - | -1,760,019 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,425,980 | -100.00% | - | Mar 31, 2024 |
| PROSIGHT MANAGEMENT, LP | - | - | - | -1,351,939 | -100.00% | - | Mar 31, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -820,971 | -100.00% | - | Mar 31, 2024 |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | - | - | - | -703,071 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -581,156 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -555,153 | -100.00% | - | Mar 31, 2024 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -447,416 | -100.00% | - | Mar 31, 2024 |
| SECTORAL ASSET MANAGEMENT INC | - | - | - | -441,829 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -434,467 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -279,194 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -204,778 | -100.00% | - | Mar 31, 2024 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -194,578 | -100.00% | - | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -186,048 | -100.00% | - | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -172,750 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | - | - | - | -135,300 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -131,068 | -100.00% | - | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -115,490 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -90,568 | -100.00% | - | Mar 31, 2024 |
| BARCLAYS PLC | - | - | - | -82,451 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -81,785 | -100.00% | - | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -76,058 | -100.00% | - | Mar 31, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | - | - | - | -65,535 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -62,753 | -100.00% | - | Mar 31, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | - | - | - | -41,060 | -100.00% | - | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -39,738 | -100.00% | - | Mar 31, 2024 |
| BBR PARTNERS, LLC | - | - | - | -36,722 | -100.00% | - | Mar 31, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -36,530 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -32,191 | -100.00% | - | Mar 31, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -31,202 | -100.00% | - | Mar 31, 2024 |
| UBS GROUP AG | - | - | - | -30,712 | -100.00% | - | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -28,584 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -28,538 | -100.00% | - | Mar 31, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -21,871 | -100.00% | - | Mar 31, 2024 |
| XTX TOPCO LTD | - | - | - | -19,475 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -18,164 | -100.00% | - | Mar 31, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -15,329 | -100.00% | - | Mar 31, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -13,929 | -100.00% | - | Mar 31, 2024 |
| INVESCO LTD. | - | - | - | -13,419 | -100.00% | - | Mar 31, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -12,368 | -100.00% | - | Mar 31, 2024 |
| MAVEN SECURITIES LTD | - | - | - | -10,000 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -9,133 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -7,673 | -100.00% | - | Mar 31, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -4,613 | -100.00% | - | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -4,521 | -100.00% | - | Mar 31, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -4,510 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -4,058 | -100.00% | - | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -4,000 | -100.00% | - | Mar 31, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -2,873 | -100.00% | - | Mar 31, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -2,677 | -100.00% | - | Mar 31, 2024 |
| AMALGAMATED BANK | - | - | - | -2,445 | -100.00% | - | Mar 31, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -2,314 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -1,700 | -100.00% | - | Mar 31, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,340 | -100.00% | - | Mar 31, 2024 |
| FMR LLC | - | - | - | -1,050 | -100.00% | - | Mar 31, 2024 |
| NORDWAND ADVISORS, LLC | - | - | - | -1,000 | -100.00% | - | Mar 31, 2024 |
LENZ Therapeutics's largest sold out institutional shareholder by shares sold is ECOR1 CAPITAL, LLC, sold -8.54M shares, valued at -, as of undefined.
LENZ Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 0.49% | 35,187 | 35,187 | - | Sep 30, 2022 |
| FIDELITY ADVISOR SERIES VII | 0.20% | 1,713,180 | - | - | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.11% | 218,767 | - | - | Feb 29, 2024 |
| BRIDGEWAY FUNDS INC | 0.07% | 162,650 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.04% | 100,000 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.04% | 401,941 | - | - | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.03% | 641,940 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,058,457 | - | - | Feb 29, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 359,803 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.01% | 14,964 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 57,691 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,419 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 554,816 | - | - | Jan 31, 2024 |
| UBS FUNDS | 0.01% | 28,450 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 236,200 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,543,891 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 63,800 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.00% | 1,081 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 81,785 | - | - | Jan 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 8,060 | - | - | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 35,187 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 310 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 264,237 | 13,258 | 5.28% | Feb 29, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 269,323 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 2,314 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 22,375 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,149 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 9,522 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 976 | - | - | Mar 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 3,123 | - | - | Mar 31, 2024 |
| FIDELITY SUMMER STREET TRUST | 0.00% | 55,459 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 21,466 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,600 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 1,565 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 274,688 | 254,477 | 1259.10% | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 1,028,502 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,386 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 256 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 120,709 | 12,306 | 11.35% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 607 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 19,808 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,300 | - | - | Mar 28, 2024 |
| MORGAN STANLEY INSTITUTIONAL FUND INC | 0.00% | 2,854 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 47,152 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 10,754 | -44 | -0.41% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,640 | -34 | -0.73% | Jan 31, 2024 |
| ProFunds | 0.00% | 399 | 164 | 69.79% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 127 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,885 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 160 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,397 | - | - | Feb 29, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 62,860 | - | - | Mar 28, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,140 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 2,000 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 4,105 | -3,210 | -43.88% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,662 | 667 | 22.27% | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 17 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 12,964 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 13,468 | 3,181 | 30.92% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 38,589 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 30,929 | - | - | Mar 31, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 6,744 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 9,262 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,175 | -13 | -0.41% | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 119 | - | - | Jan 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 6,290 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 977 | - | - | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 14,072 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 10,829 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,330 | - | - | Dec 31, 2023 |
| BLACKROCK FUNDS | 0.00% | 5,402 | -3,734 | -40.87% | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,383 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,533 | -590 | -14.31% | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 889 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 3,500 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 1,809 | - | - | Feb 29, 2024 |
LENZ Therapeutics's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 35.19K shares, compromising 0.49% of its total assets.
LENZ Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 23 | 64 | -4.48% |
| 30 Sep, 23 | 67 | -4.29% |
| 30 Jun, 23 | 70 | 11.11% |
| 31 Mar, 23 | 63 | -7.35% |
| 31 Dec, 22 | 68 | 4.62% |
| 30 Sep, 22 | 65 | 6.56% |
| 30 Jun, 22 | 61 | -1.61% |
| 31 Mar, 22 | 62 | 8.77% |
| 31 Dec, 21 | 57 | -3.39% |
| 30 Sep, 21 | 59 | 15.69% |
| 30 Jun, 21 | 51 | - |
As of 31 Dec 23, 64 institutions are holding LENZ Therapeutics's shares, representing a decrease of -4.48% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 23 | 31,066,895 | 1.64% |
| 30 Sep, 23 | 30,564,828 | -2.95% |
| 30 Jun, 23 | 31,494,796 | 5.93% |
| 31 Mar, 23 | 29,732,465 | 3.28% |
| 31 Dec, 22 | 28,787,244 | -2.76% |
| 30 Sep, 22 | 29,603,150 | -1.86% |
| 30 Jun, 22 | 30,165,680 | -17.08% |
| 31 Mar, 22 | 36,377,273 | 4.74% |
| 31 Dec, 21 | 34,732,104 | -3.44% |
| 30 Sep, 21 | 35,969,653 | 11.75% |
| 30 Jun, 21 | 32,188,993 | - |
LENZ Therapeutics (GRPH) has 31.07M shares outstanding as of 31 Dec 23, up 1.64% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 23 | 54.26% | 1.87% |
| 30 Sep, 23 | 53.86% | 1.69% |
| 30 Jun, 23 | 56.38% | 1.99% |
| 31 Mar, 23 | 53.22% | 1.99% |
| 31 Dec, 22 | 51.66% | 1.80% |
| 30 Sep, 22 | 53.62% | 1.76% |
| 30 Jun, 22 | 55.28% | 1.22% |
| 31 Mar, 22 | 67.36% | 0.47% |
| 31 Dec, 21 | 120.10% | 0.78% |
| 30 Sep, 21 | 124.38% | 1.00% |
| 30 Jun, 21 | 111.31% | - |
As of 31 Dec 23, LENZ Therapeutics is held by 54.26% institutional shareholders, representing a 1.87% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 23 | 30 | -6.25% |
| 30 Sep, 23 | 32 | -15.79% |
| 30 Jun, 23 | 38 | 26.67% |
| 31 Mar, 23 | 30 | -9.09% |
| 31 Dec, 22 | 33 | - |
| 30 Sep, 22 | 33 | -10.81% |
| 30 Jun, 22 | 37 | 12.12% |
| 31 Mar, 22 | 33 | -2.94% |
| 31 Dec, 21 | 34 | -15.00% |
| 30 Sep, 21 | 40 | -21.57% |
| 30 Jun, 21 | 51 | - |
30 institutional shareholders have increased their position in GRPH stock as of 31 Dec 23 compared to 32 in the previous quarter (a -6.25% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 23 | 18 | - |
| 30 Sep, 23 | 18 | 20.00% |
| 30 Jun, 23 | 15 | -11.76% |
| 31 Mar, 23 | 17 | 21.43% |
| 31 Dec, 22 | 14 | -6.67% |
| 30 Sep, 22 | 15 | - |
| 30 Jun, 22 | 15 | 7.14% |
| 31 Mar, 22 | 14 | 27.27% |
| 31 Dec, 21 | 11 | - |
| 30 Sep, 21 | 11 | - |
| 30 Jun, 21 | - | - |
18 institutional shareholders have reduced their position in GRPH stock as of 31 Dec 23 compared to 18 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 23 | 64 | -4.48% | 31,066,895 | 1.64% | 54.26% | 1.87% | 30 | -6.25% | 18 | - |
| 30 Sep, 23 | 67 | -4.29% | 30,564,828 | -2.95% | 53.86% | 1.69% | 32 | -15.79% | 18 | 20.00% |
| 30 Jun, 23 | 70 | 11.11% | 31,494,796 | 5.93% | 56.38% | 1.99% | 38 | 26.67% | 15 | -11.76% |
| 31 Mar, 23 | 63 | -7.35% | 29,732,465 | 3.28% | 53.22% | 1.99% | 30 | -9.09% | 17 | 21.43% |
| 31 Dec, 22 | 68 | 4.62% | 28,787,244 | -2.76% | 51.66% | 1.80% | 33 | - | 14 | -6.67% |
| 30 Sep, 22 | 65 | 6.56% | 29,603,150 | -1.86% | 53.62% | 1.76% | 33 | -10.81% | 15 | - |
| 30 Jun, 22 | 61 | -1.61% | 30,165,680 | -17.08% | 55.28% | 1.22% | 37 | 12.12% | 15 | 7.14% |
| 31 Mar, 22 | 62 | 8.77% | 36,377,273 | 4.74% | 67.36% | 0.47% | 33 | -2.94% | 14 | 27.27% |
| 31 Dec, 21 | 57 | -3.39% | 34,732,104 | -3.44% | 120.10% | 0.78% | 34 | -15.00% | 11 | - |
| 30 Sep, 21 | 59 | 15.69% | 35,969,653 | 11.75% | 124.38% | 1.00% | 40 | -21.57% | 11 | - |
| 30 Jun, 21 | 51 | - | 32,188,993 | - | 111.31% | - | 51 | - | - | - |
LENZ Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
LENZ Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | 9 | - | - |
| Q1 2023 | 2 | - | - |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 6 | - | - |
| Q4 2021 | 8 | - | - |
| Q2 2021 | 22 | 35 | 62.86% |
| Q1 2021 | 23 | 3 | 766.67% |
9 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by LENZ Therapeutics's insiders, as of Q3 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | 2 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | 8 | - | - |
| Q2 2021 | 5 | - | - |
| Q1 2021 | - | - | - |
As of Q3 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of LENZ Therapeutics's stocks.
GRPH Ownership FAQ
Who Owns LENZ Therapeutics?
LENZ Therapeutics is owned by institutional shareholders (54.26%), insiders (9.18%), and public (36.56%). The largest institutional shareholder of LENZ Therapeutics is AMERICAN INTERNATIONAL GROUP, INC. (0% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.49% of total shares).
Who are the major institutional shareholders of LENZ Therapeutics?
LENZ Therapeutics's major institutional shareholders are AMERICAN INTERNATIONAL GROUP, INC., JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, and NORTHERN TRUST CORP. The top five shareholders own together 0% of the company's share outstanding.
How many LENZ Therapeutics shareholders are there?
As of Dec 2023, there are 64 institutional shareholders of LENZ Therapeutics.
What percentage of LENZ Therapeutics is owned by AMERICAN INTERNATIONAL GROUP, INC?
AMERICAN INTERNATIONAL GROUP, INC owns 0 shares of LENZ Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).
What percentage of LENZ Therapeutics is owned by JPMORGAN CHASE & CO?
As of Mar 2024, JPMORGAN CHASE & CO holds 0 shares of LENZ Therapeutics (GRPH), compromising 0% of the company, valued at $0.
What percentage of LENZ Therapeutics is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ is the third largest holder of LENZ Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).